Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Cerium Pharmaceuticals, Inc.

Clinical trials sponsored by Cerium Pharmaceuticals, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New gel could outperform standard therapy for kidney disease Results expected Apr 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New gel could outperform standard therapy for kidney disease

Disease control Recruiting now

This Phase 3 trial is testing a new gel called SNP-ACTH (1-39) against the standard drug rituximab in 148 adults with primary membranous nephropathy, a rare kidney condition. The goal is to see if the gel can better reduce protein in the urine and protect kidney function over 24 …

Phase 3 • Sponsor: Cerium Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 14:03 UTC